Multiply Labs builds robotic biomanufacturing infrastructure for cell and gene therapies and advanced biologics. Its modular Cluster automates workflows by integrating existing GMP instruments in a closed system and learning processes through imitation learning rather than full process transfer. Digital QC software monitors real-time sensors and generates 21 CFR Part 11–compliant electronic batch records. The company partners with pharma and research institutions to expand scalable, compliant manufacturing capacity and accelerate commercial-scale product development.
Company Size
51-200
Company Stage
Series B
Total Funding
$98M
Headquarters
San Francisco, California
Founded
2016
See people who can refer or advise you
Help us improve and share your feedback! Did you find this helpful?